Ketamine has ‘fast-acting benefits’ for depression
Ketamine has “shown promise” in the rapid treatment of major depression and suicidal thoughts, a US study says.
Ketamine has a reputation as a party drug but is licensed as an anaesthetic. The study found use of the drug via a nasal spray led to “significant” improvements in depressive symptoms in the first 24 hours. The Royal College of Psychiatrists said it was a “significant” study that brought the drug “a step closer to being prescribed on the NHS”. The report by researchers from Janssen Research and Development, a Johnson and Johnson company, and Yale School of Medicine, is the first study into ketamine as a treatment for depression that has been done by a drug company. BBC News